Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

The effect of Lactiplantibacillus plantarum 299v together with a low dose of iron on iron status in healthy pregnant women : A randomized clinical trial

Axling, Ulrika LU ; Önning, Gunilla LU ; Martinsson Niskanen, Titti ; Larsson, Niklas LU ; Hansson, Stefan R. LU orcid and Hulthén, Lena (2021) In Acta Obstetricia et Gynecologica Scandinavica 100(9). p.1602-1610
Abstract

Introduction: Iron deficiency during pregnancy is a global health problem and is associated with adverse pregnancy outcomes. The aim of this randomized, double-blind, placebo-controlled study was to evaluate the effect of Lactiplantibacillus plantarum 299v (Lp299v, 1010 colony forming units), 4.2 mg iron, 12 mg ascorbic acid and 30 µg folic acid (Lp) on iron status in healthy, non-anemic, pregnant Swedish women. Material and methods: A total of 326 women were randomized to receive Lp (n = 161) or placebo (n = 165) twice daily from gestational week 10–12 until end of pregnancy or until the potential start of iron therapy. The primary endpoint was serum ferritin at week 28. Results: Intake of Lp attenuated the decrease in serum... (More)

Introduction: Iron deficiency during pregnancy is a global health problem and is associated with adverse pregnancy outcomes. The aim of this randomized, double-blind, placebo-controlled study was to evaluate the effect of Lactiplantibacillus plantarum 299v (Lp299v, 1010 colony forming units), 4.2 mg iron, 12 mg ascorbic acid and 30 µg folic acid (Lp) on iron status in healthy, non-anemic, pregnant Swedish women. Material and methods: A total of 326 women were randomized to receive Lp (n = 161) or placebo (n = 165) twice daily from gestational week 10–12 until end of pregnancy or until the potential start of iron therapy. The primary endpoint was serum ferritin at week 28. Results: Intake of Lp attenuated the decrease in serum ferritin from baseline to week 28 (p = 0.003) and week 35 (p ˂ 0.001) and resulted in reduced prevalence of iron deficiency (59% vs 78%, p = 0.017) and iron deficiency anemia (7.4% vs 21%, p = 0.023) at week 35. Intake of Lp also resulted in beneficial effects on the soluble transferrin receptor (p = 0.011) and total body iron (p ˂ 0.001) at week 35. Gestational length and birthweight were comparable between groups. The proportion of women reporting adverse events during the study was comparable between groups. Conclusions: Intake of Lp from early pregnancy was safe, attenuated the loss of iron stores and improved iron status in healthy pregnant women.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
DSM 9843, ferritin, iron absorption, iron deficiency, iron status, Lactiplantibacillus plantarum 299v, pregnancy, probiotics
in
Acta Obstetricia et Gynecologica Scandinavica
volume
100
issue
9
pages
1602 - 1610
publisher
Wiley-Blackwell
external identifiers
  • scopus:85104531967
  • pmid:33880752
ISSN
0001-6349
DOI
10.1111/aogs.14153
language
English
LU publication?
yes
id
9c3c71ed-a3c9-48b9-ae48-6a868f2f5b32
date added to LUP
2021-05-03 14:25:57
date last changed
2024-06-15 10:44:33
@article{9c3c71ed-a3c9-48b9-ae48-6a868f2f5b32,
  abstract     = {{<p>Introduction: Iron deficiency during pregnancy is a global health problem and is associated with adverse pregnancy outcomes. The aim of this randomized, double-blind, placebo-controlled study was to evaluate the effect of Lactiplantibacillus plantarum 299v (Lp299v, 10<sup>10</sup> colony forming units), 4.2 mg iron, 12 mg ascorbic acid and 30 µg folic acid (Lp) on iron status in healthy, non-anemic, pregnant Swedish women. Material and methods: A total of 326 women were randomized to receive Lp (n = 161) or placebo (n = 165) twice daily from gestational week 10–12 until end of pregnancy or until the potential start of iron therapy. The primary endpoint was serum ferritin at week 28. Results: Intake of Lp attenuated the decrease in serum ferritin from baseline to week 28 (p = 0.003) and week 35 (p ˂ 0.001) and resulted in reduced prevalence of iron deficiency (59% vs 78%, p = 0.017) and iron deficiency anemia (7.4% vs 21%, p = 0.023) at week 35. Intake of Lp also resulted in beneficial effects on the soluble transferrin receptor (p = 0.011) and total body iron (p ˂ 0.001) at week 35. Gestational length and birthweight were comparable between groups. The proportion of women reporting adverse events during the study was comparable between groups. Conclusions: Intake of Lp from early pregnancy was safe, attenuated the loss of iron stores and improved iron status in healthy pregnant women.</p>}},
  author       = {{Axling, Ulrika and Önning, Gunilla and Martinsson Niskanen, Titti and Larsson, Niklas and Hansson, Stefan R. and Hulthén, Lena}},
  issn         = {{0001-6349}},
  keywords     = {{DSM 9843; ferritin; iron absorption; iron deficiency; iron status; Lactiplantibacillus plantarum 299v; pregnancy; probiotics}},
  language     = {{eng}},
  number       = {{9}},
  pages        = {{1602--1610}},
  publisher    = {{Wiley-Blackwell}},
  series       = {{Acta Obstetricia et Gynecologica Scandinavica}},
  title        = {{The effect of Lactiplantibacillus plantarum 299v together with a low dose of iron on iron status in healthy pregnant women : A randomized clinical trial}},
  url          = {{http://dx.doi.org/10.1111/aogs.14153}},
  doi          = {{10.1111/aogs.14153}},
  volume       = {{100}},
  year         = {{2021}},
}